AR057216A1 - Composicion despigmentante de la piel que comprende un derivado de acido naftoico - Google Patents
Composicion despigmentante de la piel que comprende un derivado de acido naftoicoInfo
- Publication number
- AR057216A1 AR057216A1 ARP060105338A ARP060105338A AR057216A1 AR 057216 A1 AR057216 A1 AR 057216A1 AR P060105338 A ARP060105338 A AR P060105338A AR P060105338 A ARP060105338 A AR P060105338A AR 057216 A1 AR057216 A1 AR 057216A1
- Authority
- AR
- Argentina
- Prior art keywords
- acid derivative
- physiologically acceptable
- acceptable medium
- naftoic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composicion despigmentante de la piel que comprende, en un medio fisiologicamente aceptable, un enantiomero o una mezcla de enantiomeros de un derivado de ácido naftoico, a su utilizacion farmacéutica o cosmética. Una composicion despigmentante de la piel que comprende, en un medio fisiologicamente aceptables, un enantiomero o una mezcla de enantiomeros de un derivado de ácido naftoico y, al menos, otro agente despigmentante, y/o un filtro solar, a su utilizacion farmacéutica o cosmética. Reivindicacion 1: Utilizacion de una composicion caracterizada porque comprende, en un medio fisiologicamente aceptable, ácido 2-hidroxi-4-[3-hidroxi-3-(5,6,7,8-tetrahidro-5,5,8,8-tetrametil-2-naftil)-1-propinil]benzoico, para preparar un medicamento destinado a prevenir y/o a tratar las alteraciones hiperpigmentarias seleccionadas entre el melasma, el cloasma, el vitíligo, las pecas, los nevi, las hiperpigmentaciones de determinismo genético y las hiperpigmentaciones de origen metabolico o medicamentoso.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0512367A FR2894141A1 (fr) | 2005-12-06 | 2005-12-06 | Composition depigmentante de la peau compreant un derive d'acide naphtoique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR057216A1 true AR057216A1 (es) | 2007-11-21 |
Family
ID=36498987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060105338A AR057216A1 (es) | 2005-12-06 | 2006-12-04 | Composicion despigmentante de la piel que comprende un derivado de acido naftoico |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR057216A1 (es) |
| FR (1) | FR2894141A1 (es) |
| WO (1) | WO2007066041A2 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2931663B1 (fr) * | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes anhydre comprenant un derive phenolique solubilise. |
| FR2931661B1 (fr) | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713635B1 (fr) * | 1993-12-15 | 1996-01-05 | Cird Galderma | Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. |
| FR2752734B1 (fr) * | 1996-09-02 | 1998-11-06 | Cird Galderma | Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf |
| KR20050085740A (ko) * | 2002-12-17 | 2005-08-29 | 갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨. | 염기를 이용하여 용매 내에서 가용화된 레티노이드를화학적으로 안정화시키는 방법 |
| FR2863266B1 (fr) * | 2003-12-08 | 2006-01-27 | Galderma Res & Dev | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINES HUMAINE AINSI QU'EN COSMETIQUE |
-
2005
- 2005-12-06 FR FR0512367A patent/FR2894141A1/fr not_active Withdrawn
-
2006
- 2006-12-04 AR ARP060105338A patent/AR057216A1/es not_active Application Discontinuation
- 2006-12-06 WO PCT/FR2006/051289 patent/WO2007066041A2/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| FR2894141A1 (fr) | 2007-06-08 |
| WO2007066041A2 (fr) | 2007-06-14 |
| WO2007066041A3 (fr) | 2007-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rendon et al. | Review of skin‐lightening agents | |
| US20090053290A1 (en) | Transdermal drug delivery compositions and topical compositions for application on the skin | |
| ES2289315T3 (es) | Composicion despigmentante para la piel que contiene adapaleno y al menos un agente despigmentante. | |
| US20070166251A1 (en) | Composition and method for treating hyperpigmented skin | |
| RS51764B (en) | TRANSDERMAL PHARMACEUTICAL COMPOSITION | |
| WO2008148967A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
| JP2012515218A (ja) | 皮膚色素沈着の障害および状態を処置するカルシウム封鎖組成物および方法 | |
| US8911774B2 (en) | Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use | |
| ES2692188T3 (es) | Composición cosmética para el rejuvenecimiento de la piel | |
| JP6815730B2 (ja) | キャノーラエキスの使用による皮膚のホワイトニング方法 | |
| WO2009004995A1 (ja) | 生理活性物質を定着および発現させる方法 | |
| JP2013526550A (ja) | 皮膚色素沈着過剰のアシルグルタチオン治療 | |
| KR20090103992A (ko) | 감마-아미노 부티르산의 탈색제로서 용도 | |
| AR057216A1 (es) | Composicion despigmentante de la piel que comprende un derivado de acido naftoico | |
| RU2010153985A (ru) | Безводные депигментирующие композиции, содержащие в жировом компоненте солюбилизированное фенольное производное и ретиноид | |
| AR040515A1 (es) | Formula farmaceutica topica estabilizada con contenido de ketoprofeno | |
| EP1592397A1 (en) | Improved formulation for skin-lightening agents | |
| Galappatthy et al. | Depigmenting agents | |
| DE502005001398D1 (de) | Hautpflegeprodukt enthaltend Ursolsäure und Ginkgo-Extrakt | |
| Cheng et al. | Treatment strategies for hyperpigmentation | |
| ES2396572T3 (es) | Utilización de una composición que comprende una asociación de hidroquinona de acetonida, de fluocinolona, y de tretinoina, destinada al tratamiento de los signos cutáneos de fotoenvejecimiento | |
| ATE323534T1 (de) | Hautkosmetische zubereitungen zur depigmentierung und deren verwendung | |
| AR041145A1 (es) | Composicion despigmentante de la piel que comprende adapaleno y al menos un agente despigmentante | |
| Abad-Casintahan et al. | Topical agents in melasma | |
| Fidalgo et al. | Resveratrol: Apromising Antiaging Agent for Cosmetic Skin Treatments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |